APA (7th ed.) Citation

Balzer, M. S., Rong, S., Nordlohne, J., Zemtsovski, J. D., Schmidt, S., Stapel, B., . . . Shushakova, N. (2020). SGLT2 inhibition by intraperitoneal dapagliflozin mitigates peritoneal fibrosis and ultrafiltration failure in a mouse model of chronic peritoneal exposure to high-glucose dialysate. Biomolecules, 10(11), . https://doi.org/10.3390/biom10111573

Chicago Style (17th ed.) Citation

Balzer, Michael S., et al. "SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-glucose Dialysate." Biomolecules 10, no. 11 (2020). https://doi.org/10.3390/biom10111573.

MLA (9th ed.) Citation

Balzer, Michael S., et al. "SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-glucose Dialysate." Biomolecules, vol. 10, no. 11, 2020, https://doi.org/10.3390/biom10111573.